Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Argus Health
Cantor Fitzgerald
McKinsey
Johnson and Johnson
UBS
Express Scripts
Novartis
Julphar

Generated: February 20, 2018

DrugPatentWatch Database Preview

NITROFURAZONE Drug Profile

« Back to Dashboard

Which patents cover Nitrofurazone, and what generic alternatives are available?

Nitrofurazone is a drug marketed by Ambix, Lannett, Perrigo New York, Taro, and Wendt. and is included in seven NDAs.

The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
Drug patent expirations by year for NITROFURAZONE
Medical Subject Heading (MeSH) Categories for NITROFURAZONE

US Patents and Regulatory Information for NITROFURAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ambix NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086077-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wendt NITROFURAZONE nitrofurazone SOLUTION;TOPICAL 087081-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Taro NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086156-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 084393-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo New York NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 084968-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo New York NITROFURAZONE nitrofurazone SOLUTION;TOPICAL 085130-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wendt NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086766-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
Fish and Richardson
Cantor Fitzgerald
AstraZeneca
Harvard Business School
Moodys
Baxter
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot